Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study
- 30 July 1994
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 344 (8918), 293-298
- https://doi.org/10.1016/s0140-6736(94)91338-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994
- Treatment of Multidrug-Resistant TuberculosisThe New England Journal of Medicine, 1993
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- The Emergence of Drug-Resistant Tuberculosis in New York CityThe New England Journal of Medicine, 1993
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992
- Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patientsJAMA, 1992
- The New TuberculosisThe New England Journal of Medicine, 1992
- Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control ProgramsAmerican Review of Respiratory Disease, 1991
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionThe New England Journal of Medicine, 1991